Cite
MLA Citation
Jens Y Humrich et al.. “Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial.” Lancet, vol. 1, 2019, pp. e44–e54. http://access.bl.uk/ark:/81055/vdc_100101587896.0x000001